18-31598586-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM1BP6BS2_Supporting
The ENST00000237014.8(TTR):c.355G>A(p.Asp119Asn) variant causes a missense change. The variant allele was found at a frequency of 0.0000781 in 1,613,920 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D119A) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000237014.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TTR | NM_000371.4 | c.355G>A | p.Asp119Asn | missense_variant | 4/4 | ENST00000237014.8 | NP_000362.1 | |
LOC124904277 | XR_007066326.1 | n.129-2891C>T | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TTR | ENST00000237014.8 | c.355G>A | p.Asp119Asn | missense_variant | 4/4 | 1 | NM_000371.4 | ENSP00000237014 | P1 | |
TTR | ENST00000649620.1 | c.355G>A | p.Asp119Asn | missense_variant | 6/6 | ENSP00000497927 | P1 | |||
TTR | ENST00000610404.5 | c.259G>A | p.Asp87Asn | missense_variant | 4/4 | 5 | ENSP00000477599 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152138Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000279 AC: 7AN: 250980Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135688
GnomAD4 exome AF: 0.0000794 AC: 116AN: 1461782Hom.: 0 Cov.: 31 AF XY: 0.0000963 AC XY: 70AN XY: 727204
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152138Hom.: 0 Cov.: 33 AF XY: 0.0000673 AC XY: 5AN XY: 74304
ClinVar
Submissions by phenotype
Amyloidosis, hereditary systemic 1 Uncertain:1Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 02, 2024 | This sequence change replaces aspartic acid, which is acidic and polar, with asparagine, which is neutral and polar, at codon 119 of the TTR protein (p.Asp119Asn). This variant is present in population databases (rs76410435, gnomAD 0.02%). This missense change has been observed in individual(s) with clinical features of TTR-related conditions (PMID: 32376792, 34658264; Invitae). This variant is also known as D99N. ClinVar contains an entry for this variant (Variation ID: 181690). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt TTR protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change does not substantially affect TTR function (PMID: 21406045). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Dec 20, 2017 | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Dec 08, 2020 | In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 21406045, 30683924, 32376792) - |
Charcot-Marie-Tooth disease Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Molecular Genetics Laboratory, London Health Sciences Centre | - | - - |
Cardiovascular phenotype Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 23, 2020 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at